Merrimack Pharmaceuticals, Inc. MACK
15.15 0.00 0.00%
As of May 17, 3:59 PM ET
52-week range unavailable
- Open
- 15.15
- Prev close
- 15.15
- Mkt cap
- 223.75M
- Vol
- 922.50K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 100.00%
More statistics
- Low
- 15.14
- High
- 15.17
- Forward P/E
- -8.50
- Beta
- 1.42
- Short ratio
- 8.65
- Inst. own
- 62.98%
- Dividend
- 15.10
- Ex-div date
- May 8, 2024
- Earnings
- May 15, 2024
- 50-d avg
- 14.84
- 200-d avg
- 13.48
- 1y target
- 0.00
5D chart
Chart tools
Chart is warming up
The five-day price history for MACK has not been loaded yet. Try again in a moment.
Altman Z-Score
5.01 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -162×
P/S 0.0×
P/B 10.2×
P/FCF -126×
EV/EBITDA 85.4×
EV/Sales 0.0×
FCF Yield -0.8%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -6.3%
ROIC -11.6%
ROA -6.2%
Revenue 0.0%
Operating Income -25.9%
EPS (diluted) 24.9%
Free Cash Flow 12.6%
Current Ratio 43.5×
Quick Ratio 43.5×
Debt / Equity 0.0×
Net Debt / EBITDA -2.8×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31